Cite
HARVARD Citation
Hamid, M. et al. (2018). Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer. Journal of community hospital internal medicine perspectives. 8 (3), pp. 130-133. [Online].